Introduction: The Acibadem Health Group (AHG) has been using telepathology/digital pathology stations since 2006. In 2013, the system was changed from videoconferencing to digital pathology (whole-slide imaging) utilizing 3DHISTECH scanners and software. In 2017, digital cytology started to be used for routine cytopathologic diagnosis for thyroid fine-needle aspiration (FNA) cases. Material and Methods: Two hundred and twenty-seven thyroid cases were received for analysis using telecytology (TC) during the period from November 2017 to May 2018. Rapid on-site evaluation was performed at the Atakent Hospital of the AHG by a cytotechnologist and scanned on the same day. For every case, there were Diff-Quik- and Papanicolaou-stained FNA smears. Each glass slide was digitized with a 3DHISTECH whole-slide scanner in 1 focal Z-plane at ×40 magnification. Results: Two hundred and twenty-seven thyroid FNA specimens were retrieved, of which 25 had histologic follow-up. Samples were classified as nondiagnostic in 3%, benign in 74%, atypia of undetermined significance/follicular lesion of undetermined significance in 13%, suspicious for follicular neoplasia/follicular neoplasia in 3%, suspicious for malignancy in 4%, and malignant in 3%. When only the “suspicious for malignancy” and “malignancy” categories were considered positive tests, cytology sensitivity and specificity using TC for diagnosis was 100%. Conclusions: Our data demonstrate that TC is suitable to provide a primary diagnosis in daily routine cytology practice. Despite the promising results, there were some challenges stemming from the novelty of using TC for the primary diagnosis. The study also addresses both advantages and disadvantages of TC in daily practice to increase the efficiency of the technique in primary diagnosis.

1.
Chantziantoniou
N
,
Mukherjee
M
,
Donnelly
AD
,
Pantanowitz
L
,
Austin
RM
.
Digital Applications in Cytopathology: Problems, Rationalizations, and Alternative Approaches
.
Acta Cytol
.
2018
;
62
(
1
):
68
76
.
[PubMed]
0001-5547
2.
Monaco
SE
,
Koah
AE
,
Xing
J
,
Ahmed
I
,
Cuda
J
,
Cunningham
J
, et al.
Telecytology implementation: deployment of telecytology for rapid on-site evaluations at an Academic Medical Center
.
Diagn Cytopathol
.
2019
Mar
;
47
(
3
):
206
13
.
[PubMed]
8755-1039
3.
Caron
JE
,
Ying
Y
,
Ye
Q
,
Cheng
L
,
Rao
JY
.
International telecytology: current applications and future potential
.
Diagn Cytopathol
.
2019
Jan
;
47
(
1
):
28
34
.
[PubMed]
8755-1039
4.
Canberk
S
,
Ince
U
,
Schmitt
F
.
Telecytology: “Cells beyond the borders”-The example in two countries
.
Diagn Cytopathol
.
2017
May
;
45
(
5
):
381
3
.
[PubMed]
8755-1039
5.
Gerhard
R
,
Teixeira
S
,
Gaspar da Rocha
A
,
Schmitt
F
.
Thyroid fine-needle aspiration cytology: is there a place to virtual cytology?
Diagn Cytopathol
.
2013
Sep
;
41
(
9
):
793
8
.
[PubMed]
8755-1039
6.
Lee
YB
,
Cho
YY
,
Jang
JY
,
Kim
TH
,
Jang
HW
,
Chung
JH
,
Oh
YL
,
Kim
SW
:
Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.
Head Neck.
2017
F; 39(2):269-274.
7.
Bongiovanni
M
,
Spitale
A
,
Faquin
WC
,
Mazzucchelli
L
,
Baloch
ZW
.
The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis
.
Acta Cytol
.
2012
;
56
(
4
):
333
9
.
[PubMed]
0001-5547
8.
Cibas
ES
,
Ali
SZ
.
The 2017 Bethesda System for Reporting Thyroid Cytopathology
.
Thyroid
.
2017
Nov
;
27
(
11
):
1341
6
.
[PubMed]
1050-7256
9.
Canberk
S
,
Gunes
P
,
Onenerk
M
,
Erkan
M
,
Kilinc
E
,
Kocak Gursan
N
, et al.
New Concept of the Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and Its Impact on the Bethesda System for Reporting Thyroid Cytopathology: A Single-Institute Experience
.
Acta Cytol
.
2016
;
60
(
3
):
198
204
.
[PubMed]
0001-5547
10.
Têtu
B
,
Perron
É
,
Louahlia
S
,
Paré
G
,
Trudel
MC
,
Meyer
J
.
The Eastern Québec Telepathology Network: a three-year experience of clinical diagnostic services
.
Diagn Pathol
.
2014
;
9
(
S1
Suppl 1
):
S1
.
[PubMed]
1746-1596
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.